Comparative inhibitory potential of selected dietary bioactive polyphenols, phytosterols on CYP3A4 and CYP2D6 with fluorometric high-throughput screening

Journal of Food Science and Technology

Volumn 52, Issue 7, 2015, Pages 4537-4543

  Vijayakumar, Thangavel Mahalingam ^a   Kumar, Ramasamy Mohan ^a   Agrawal, Aruna ^b   Dubey, Govind Prasad ^b   Ilango, Kaliappan ^a  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

CYP3A4 CYP2D6; CYP450 CO complex assay; Cytochrome P450; Food drug interaction; Interaction potential

Indexed keywords

ALCOHOLS; CONTROLLED DRUG DELIVERY; DRUG INTERACTIONS; FLAVONOIDS; FOOD ADDITIVES; LIVER; MOLECULES; NUTRITION; PHENOLS; RAT CONTROL; RATS; VITAMINS;

BIOACTIVE COMPOUNDS; BIOACTIVE MOLECULES; CO COMPLEXES; CO-ADMINISTERED DRUGS; CYTOCHROME P450; HIGH THROUGHPUT SCREENING; INTERACTION POTENTIALS; RAT LIVER MICROSOMES;

DIETARY SUPPLEMENTS;

EID: 85027919967     PISSN: 00221155     EISSN: 09758402     Source Type: Journal    
DOI: 10.1007/s13197-014-1472-x     Document Type: Article

References (28)

1. Benet LZ, Wacher VJ (2000) Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds. Patents, Google
2. Bradford PG, Awad AB (2007) Phytosterols as anticancer compounds. Mol Nutr Food Res 51(2):161-170. doi:10.1002/mnfr.200600164
3. Choi JS, Piao YJ, Kang KW (2011) Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin. Arch Pharm Res 34(4):607-613. doi:10.1007/s12272-011-0411-x
4. Conquer JA, Maiani G, Azzini E, Raguzzini A, Holub BJ (1998) Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J Nutr 128(3):593-597
5. Deschner EE, Ruperto JF, Wong GY, Newmark HL (1993) The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. Nutr Cancer 20(3):199-204. doi:10.1080/01635589309514287
6. Erlund I, Kosonen T, Alfthan G, Maenpaa J, Perttunen K, Kenraali J, Parantainen J, Aro A (2000) Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol 56(8):545-553
7. Erlund I, Silaste ML,Alfthan G, Rantala M, Kesaniemi YA, Aro A(2002) Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables. Eur J Clin Nutr 56(9):891-898
8. Gubler H, Schopfer U, Jacoby E (2013) Theoretical and experimental relationships between percent inhibition and IC50 data observed in high-throughput screening. J Biomol Screen 18(1):1-13. doi:10. 1177/1087057112455219
9. Ho PC, Saville DJ,Wanwimolruk S (2001) Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J Pharm& Pharm Sci: Publof the Can Soc Pharm Sci, Societe canadienne des sciences pharmaceutiques 4(3):217-227
10. Hodek P, Trefil P, Stiborova M (2002) Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact 139(1):1-21
11. Hsu PW, Shia CS, Lin SP, Chao PD, Juang SH, Hou YC (2013) Potential risk ofmulberry-drug interaction:modulation on P-glycoprotein and cytochrome P450 3A. J Agric Food Chem 61(18):4464-4469
12. Huang SM, Hall SD, Watkins P, Love LA, Serabjit-Singh C, Betz JM, Hoffman FA, Honig P, Coates PM, Bull J, Chen ST, Kearns GL, Murray MD (2004) Drug interactions with herbal products and grapefruit juice: a conference report. Clin Pharmacol Ther 75(1): 1-12. doi:10.1016/j.clpt.2003.07.002
13. Ilango K, Vijayakumar TM, Agrawal A, Dubey GP (2013) Pharmacogenetic comprised prospect on cytochrome P450 facilitated drug interactions. J Bionanoscience 7(2):127-139. doi:10.1166/ jbns.2013.1106
14. Jones PJ, Abu Mweis SS (2009) Phytosterols as functional food ingredients: linkages to cardiovascular disease and cancer. Curr Opin Clin Nutr and metabolic care 12(2):147-151
15. Kim YS, Zerin T, Song HY (2013) Antioxidant action of ellagic acid ameliorates paraquat-induced A549 cytotoxicity. Biol Pharm Bull 36(4):609-615
16. Li X, Choi JS (2009) Effects of quercetin on the pharmacokinetics of etoposide after oral or intravenous administration of etoposide in rats. Anticancer Res 29(4):1411-1415
17. Manach C, Morand C, Demigné C, Texier O, Régérat F, Rémésy C (1997) Bioavailability of rutin and quercetin in rats. FEBS Lett 409(1):12-16. doi:10.1016/S0014-5793(97)00467-5
18. Mansouri MT, Soltani M, Naghizadeh B, Farbood Y, Mashak A, Sarkaki A (2014) A possible mechanism for the anxiolytic-like effect of gallic acid in the rat elevated plus maze. Pharmacol Biochem Behav 117(0):40-46. doi:10.1016/j.pbb.2013.12.011
19. Muti P, Awad AB, Schunemann H, Fink CS, Hovey K, Freudenheim JL, Wu YW, Bellati C, Pala V, Berrino F (2003) A plant food-based diet modifies the serum beta-sitosterol concentration in hyperandrogenic postmenopausal women. J Nutr 133(12):4252-4255
20. Noroozi M, Burns J, Crozier A, Kelly IE, Lean ME (2005) Prediction of dietary flavonol consumption from fasting plasma concentration or urinary excretion. Eur J Clin Nutr 54(2):143-149
21. Pandit S, Ponnusankar S, Bandyopadhyay A, Ota S, Mukherjee PK (2011) Exploring the possible metabolism mediated interaction of glycyrrhiza glabra extract with CYP3A4 and CYP2D6. Phytother Res 25(10):1429-1434
22. Ponnusankar S, Pandit S, Babu R, Bandyopadhyay A, Mukherjee PK (2011) Cytochrome P450 inhibitory potential of triphala-a rasayana from ayurveda. J Ethnopharmacol 133(1):120-125. doi:10.1016/j. jep.2010.09.022
23. Schroder-Aasen T, Molden G, Nilsen OG (2012) In vitro inhibition of CYP3A4 by the multiherbal commercial product sambucus force and its main constituents Echinacea purpurea and sambucus nigra. Phytother Res: PTR 26(11):1606-1613. doi:10.1002/ptr.4619
24. Stresser DM, Blanchard AP, Turner SD, Erve JC, Dandeneau AA,Miller VP, Crespi CL (2000) Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. Drug Metab Dispos: Biol Fate of Chem 28(12):1440-1448
25. Subehan UT, Iwata H, Kadota S, Tezuka Y (2006) Mechanism-based inhibition of CYP3A4 and CYP2D6 by Indonesian medicinal plants. J Ethnopharmacol 105(3):449-455. doi:10.1016/j.jep.2005.12.001
26. Tang JC, Yang H, Song XY, Song XH, Yan SL, Shao JQ, Zhang TL, Zhang JN (2009) Inhibition of cytochrome P450 enzymes by rhein in rat liver microsomes. Phytother Res: PTR 23(2):159-164. doi:10. 1002/ptr.2572
27. Usia T, Watabe T, Kadota S, Tezuka Y (2005) Cytochrome P450 2D6 (CYP2D6) inhibitory constituents of Catharanthus roseus. Biol Pharm Bull 28(6):1021-1024
28. Zou L, Harkey MR, Henderson GL (2002) Effects of herbal components on c DNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci 71(13):1579-1589